What an inspiring evening of innovation and collaboration! Last Thursday, Eagle IP was honored to once again host the American Intellectual Property Law Association (AIPLA) Women in IP Global Networking Event in Hong Kong, joining forces with hundreds of remarkable women across 40+ global cities.

In the spirit of this year’s theme “Innovation and Collaboration,” we gathered fellow female leaders, innovators, entrepreneurs and IP practitioners to share their amazing career journeys and lessons learnt along the way. We started off the evening with Jennifer Che and Pauli Wong, sharing their paths from scientists that transitioned into an IP career, and what it means to them now to support scientists as IP professionals. We were also privileged to have Dr. Cathy Jim, of RHT Industries Limited, share with us her inspiring journey as a Chemist and Entrepreneur. Cathy recounted how she and her team overcame many difficulties along their path to providing a better solution to real world air quality problems through science. Her one piece of advice and guiding principle? Resilience. At 8PM HKT, we promptly dialed into a joint video call to say hello to hundreds of women at 40+ participating cities around the world holding their own simultaneous events.

To all who joined us: thank you for your lively participation and sharing. Together, we’re not just shaping the future of innovation—we’re redefining what it means to lead. Here’s to many more years of collaboration, growth, and breaking barriers!

我們過去活動

Recommended Insights

Tapentadol.svg

Polymorph Patents in China: What is the Standard for Inventiveness for New Crystal Forms?

2020年7月14日
This case is focused on polymorphs, namely what are the standards for novelty and inventiveness when it comes to new crystal forms of a known drug? A recent Supreme People’s Court decision in China is illustrative of the way Chinese courts are thinking about polymorph patents in China. Grünenthal is a German pharmaceutical company and […]

Stay Ahead: Getting a Chinese Patent in Three Months?

2024年4月23日
The China National Intellectual Property Administration (CNIPA) has announced a significant development in the realm of patent prosecution: the initiation of the "PPH Improvement Initiative" in collaboration with key patent offices from the United States, Europe, Japan, and South Korea. This initiative aims to elevate the user experience of the Patent Prosecution Highway (PPH) by […]

Do Promotional Marketing Materials Constitute an “Offer for Sale” under Chinese Patent Law? Bayer IP GmbH v. Nanjing Hang Seng Pharmaceutical

2023年12月12日
Bayer's blockbuster drug Rivaroxaban has seen its share of patent litigations in China, several of which are big enough to be listed as Top 10 IP cases or 50 Representative IP cases. We summarized an invalidation case back in 2020 where all of Bayer’s claims directed towards the compound were upheld. Recently, another Rivaroxaban case […]

SPC Upholds $2M RMB Award in China’s First Patent Case on a Biological Deposit

2022年7月4日
On 28 Feb 2022, China’s Supreme People’s Court (SPC) issued its annual “Judgment Digests”, which includes a list of “48 typical cases” highlighting representative SPC decisions in 2021. The Judgment Digests help us understand more about the SPC’s judicial ideology, trial concepts, and adjudication methods in dealing with difficult and sophisticated legal issues as well […]
Top crossarrow-right